Cargando…
Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
Concerns remain regarding the rare cardiovascular adverse events, myocarditis and pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 vaccination. Our study aimed to comprehensively assess potential safety signals related to these cardiac events following the...
Autores principales: | Alami, Abdallah, Villeneuve, Paul J., Farrell, Patrick J., Mattison, Donald, Farhat, Nawal, Haddad, Nisrine, Wilson, Kumanan, Gravel, Christopher A., Crispo, James A. G., Perez-Lloret, Santiago, Krewski, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419493/ https://www.ncbi.nlm.nih.gov/pubmed/37568373 http://dx.doi.org/10.3390/jcm12154971 |
Ejemplares similares
-
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
por: Alami, Abdallah, et al.
Publicado: (2023) -
Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022) -
Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre
por: Istampoulouoglou, Ioanna, et al.
Publicado: (2021) -
Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study
por: Farhat, Nawal, et al.
Publicado: (2020) -
COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)